Peroxisome Proliferator-Activated Receptor Gamma and Lung Cancer Biology: Implications for Therapy
2008
PPARγ and Lung Cancer: Understanding the Connection
publication
Evidence: moderate
Author Information
Author(s): Han Shou Wei, Roman Jesse
Primary Institution: Emory University School of Medicine
Hypothesis
How does PPARγ affect lung carcinoma cell biology and its potential as a therapeutic target?
Conclusion
PPARγ activation is associated with decreased lung carcinoma cell proliferation and may serve as a therapeutic target.
Supporting Evidence
- PPARγ is linked to the inhibition of lung carcinoma cell growth.
- Activation of PPARγ can induce apoptosis in lung cancer cells.
- PPARγ ligands have shown potential in reducing tumor growth in animal models.
- The expression of PPARγ correlates with tumor histological type and grade.
Takeaway
PPARγ is a protein that can help stop lung cancer cells from growing, and scientists are studying how to use it to treat lung cancer.
Methodology
This review summarizes existing research on PPARγ and its effects on lung cancer cell biology.
Limitations
The exact mechanisms of PPARγ in lung cancer are not fully understood, and there may be PPARγ-independent pathways involved.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website